Skip to main content

Table 2 The characteristics of survivors and non-survivors during extracorporeal membrane oxygenation support

From: The pre-ECMO simplified acute physiology score II as a predictor for mortality in patients with initiation ECMO support at the emergency department for acute circulatory and/or respiratory failure: a retrospective study

 

Non-survivors

Survivors

p-value

n = 34

n = 31

ECMO modes

  

0.018

VA mode

31

21

 

Change from VA to VV

-

1

 

Change from VA to V-AV

1

-

 

Change from VA to V-AV, and then to VV

-

1

 

V-AV mode

2

1

 

Change from V-AV to VV

1

-

 

VV mode

1

9

 

Anticoagulants

  

0.179

Nafamostat mesilate

30

26

 

Heparin

2

5

 

ECMO run of ≤24 h

9

1

0.014a

Surgery after ECMO

-

4

0.046a

ECMO duration, h

72.5 (23.8, 118)

143.0 (93, 212)

0.001

CRRT

18 (60 %)

5 (71 %)

0.687a

Daily blood transfusion, unit/d

-

-

 

Packed red blood cells

1.9 (0.9, 3.0)

1.0 (0.7, 1.3)

0.002

Fresh frozen plasma

1.0 (0.5, 2.4)

0.3 (0.0, 0.7)

0.001

Platelet concentrate

1.7 (0.0, 5.0)

1.3 (0.0, 3.3)

0.823

Length of stay

   

ICU

4 (2, 7)

18 (11, 30)

<0.001

Hospital

4 (2, 7)

28 (20, 51)

<0.001

  1. aFisher’s exact test. Continuous variables are reported as median (interquartile range)
  2. ECMO extracorporeal membrane oxygenation, VA veno-arterial, VV veno-venous, V-AV veno-arteriovenous, CRRT continuous renal replacement therapy, ICU intensive care unit
  3. Surgeries included two pulmonary artery thromboembolectomies, a left upper lobectomy, and an aneurysm clipping via a left frontotemporal craniectomy